Search details
1.
Upper and/or Lower Respiratory Tract Infection Caused by Human Metapneumovirus After Allogeneic Hematopoietic Stem Cell Transplantation.
J Infect Dis
; 229(1): 83-94, 2024 Jan 12.
Article
in English
| MEDLINE | ID: mdl-37440459
2.
Nocardia Infections in Hematopoietic Cell Transplant Recipients: A Multicenter International Retrospective Study of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation.
Clin Infect Dis
; 75(1): 88-97, 2022 08 24.
Article
in English
| MEDLINE | ID: mdl-34596213
3.
Current attitude to deferral of cellular therapy or nontransplant chemotherapy due to SARS-CoV-2 asymptomatic infection: Survey of Infectious Diseases Working Party EBMT.
Transpl Infect Dis
; 24(2): e13773, 2022 Apr.
Article
in English
| MEDLINE | ID: mdl-34918856
4.
Prevalence, management, and new treatment modalities of EBV-DNA-emia and EBV-PTLD after allo-HCT: survey of Infectious Diseases Working Party EBMT.
Bone Marrow Transplant
; 59(1): 59-65, 2024 01.
Article
in English
| MEDLINE | ID: mdl-37872300
5.
Listeria monocytogenes Infections in Hematopoietic Cell Transplantation Recipients: Clinical Manifestations and Risk Factors. A Multinational Retrospective Case-Control Study from the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation.
Transplant Cell Ther
; 2024 Apr 15.
Article
in English
| MEDLINE | ID: mdl-38621480
6.
Risk factors for Nocardia infection among allogeneic hematopoietic cell transplant recipients: A case-control study of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation.
J Infect
; 88(6): 106162, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38663756
7.
Influence of invasive aspergillosis during acute leukaemia treatment on survival after allogeneic stem cell transplantation: a prospective study of the EBMT Infectious Diseases Working Party.
EClinicalMedicine
; 67: 102393, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-38152413
8.
New trends in the management of cytomegalovirus infection after allogeneic hematopoietic cell transplantation: a survey of the Infectious Diseases Working Pary of EBMT.
Bone Marrow Transplant
; 58(2): 203-208, 2023 02.
Article
in English
| MEDLINE | ID: mdl-36396949
9.
Decrease of lethal infectious complications in the context of causes of death (COD) after hematopoietic cell transplantation: COD-2 and COD-1 study of the Infectious Diseases Working Party EBMT.
Bone Marrow Transplant
; 58(8): 881-892, 2023 08.
Article
in English
| MEDLINE | ID: mdl-37149673
10.
HEV infection in stem cell transplant recipients-retrospective study of EBMT Infectious Diseases Working Party.
Bone Marrow Transplant
; 57(2): 167-175, 2022 02.
Article
in English
| MEDLINE | ID: mdl-34689177
11.
Thiotepa-busulfan-fludarabine (TBF) conditioning regimen in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis: an outcome analysis from the Chronic Malignancies Working Party of the EBMT.
Bone Marrow Transplant
; 56(7): 1593-1602, 2021 07.
Article
in English
| MEDLINE | ID: mdl-33526919
12.
Use of letermovir in off-label indications: Infectious Diseases Working Party of European Society of Blood and Marrow Transplantation retrospective study.
Bone Marrow Transplant
; 56(5): 1171-1179, 2021 05.
Article
in English
| MEDLINE | ID: mdl-33288863
13.
Discrepancies in the management of Clostridioides difficile infections in patients after allogeneic haematopoietic cell transplantation: the results of the Infectious Diseases Working Party EBMT survey.
Bone Marrow Transplant
; 57(4): 685-687, 2022 04.
Article
in English
| MEDLINE | ID: mdl-35145219
Results
1 -
13
de 13
1
Next >
>>